CITIES DESPITE RUSSIA‘S PROMISES PRESIDENT BIDEN. MEANWHILE
PROMISES PRESIDENT BIDEN. MEANWHILE BUT
PRESIDENT BIDEN. MEANWHILE BUT THIS TIME,
BUT THIS TIME, IT WAS NOT ABOUT UKRAINE,
THIS TIME, IT WAS NOT ABOUT UKRAINE, BUT ABOUT THE ONGOING
IT WAS NOT ABOUT UKRAINE, BUT ABOUT THE ONGOING COVID PANDEMIC. AFTER HIS
BUT ABOUT THE ONGOING COVID PANDEMIC. AFTER HIS SPEECH THE PRESIDENT GOT HIS
COVID PANDEMIC. AFTER HIS SPEECH THE PRESIDENT GOT HIS SECOND BOOSTER SHOT ON CAMERA.
SPEECH THE PRESIDENT GOT HIS SECOND BOOSTER SHOT ON CAMERA. TO ENCOURAGE OTHER ELIGIBLE
SECOND BOOSTER SHOT ON CAMERA. TO ENCOURAGE OTHER ELIGIBLE AMERICANS TO DO THE SAME
TO ENCOURAGE OTHER ELIGIBLE AMERICANS TO DO THE SAME THING. ALL FULLY VACCINATED.
AMERICANS TO DO THE SAME THING. ALL FULLY VACCINATED. ADULTS WHO ARE AGE
THING. ALL FULLY VACCINATED. ADULTS WHO ARE AGE 50 AND OVER OR
ADULTS WHO ARE AGE 50 AND OVER OR IMMUNOCOMPROMISED ARE NOW
50 AND OVER OR IMMUNOCOMPROMISED ARE NOW ELIGIBLE FOR A SECOND
IMMUNOCOMPROMISED ARE NOW ELIGIBLE FOR A SECOND BOOSTER SHOT, WHICH IS
ELIGIBLE FOR A SECOND BOOSTER SHOT, WHICH IS BUT THE APPROVAL
BOOSTER SHOT, WHICH IS BUT THE APPROVAL COMES AS A NEW
BUT THE APPROVAL COMES AS A NEW COVID
COMES AS A NEW COVID SUB VARIANT
COVID SUB VARIANT BE A TO
SUB VARIANT BE A TO HAS SPREAD TO BECOME THE
BE A TO HAS SPREAD TO BECOME THE DOMINANT VARIANT IN ALL OF THE
HAS SPREAD TO BECOME THE DOMINANT VARIANT IN ALL OF THE UNITED
DOMINANT VARIANT IN ALL OF THE UNITED STATES. AND YOU CAN SEE
UNITED STATES. AND YOU CAN SEE THAT ON THE PINK BARS ON THE
STATES. AND YOU CAN SEE THAT ON THE PINK BARS ON THE RIGHT SIDE OF THE CHART
THAT ON THE PINK BARS ON THE RIGHT SIDE OF THE CHART SHARPLY.
RIGHT SIDE OF THE CHART SHARPLY. SO,
SHARPLY. SO, THE IMPORTANT QUESTION RIGHT
SO, THE IMPORTANT QUESTION RIGHT NOW IS, WILL THE
THE IMPORTANT QUESTION RIGHT NOW IS, WILL THE U.S. BE PREPARED? IF THERE IS
NOW IS, WILL THE U.S. BE PREPARED? IF THERE IS ANOTHER COVID SURGE
U.S. BE PREPARED? IF THERE IS ANOTHER COVID SURGE AND IT‘S A REALLY, REALLY
ANOTHER COVID SURGE AND IT‘S A REALLY, REALLY STATES ACROSS THE COUNTRY.
AND IT‘S A REALLY, REALLY STATES ACROSS THE COUNTRY. HAVE
STATES ACROSS THE COUNTRY. HAVE LAUGHS. THEY‘RE COVID
HAVE LAUGHS. THEY‘RE COVID RESTRICTIONS AND SCENES LIKE
LAUGHS. THEY‘RE COVID RESTRICTIONS AND SCENES LIKE THIS. SOME PEOPLE WEARING
RESTRICTIONS AND SCENES LIKE THIS. SOME PEOPLE WEARING MASKS IN PUBLIC
THIS. SOME PEOPLE WEARING MASKS IN PUBLIC ARE BECOMING LESS AND LESS
MASKS IN PUBLIC ARE BECOMING LESS AND LESS STATES ARE SUING THE FEDERAL
ARE BECOMING LESS AND LESS STATES ARE SUING THE FEDERAL GOVERNMENT TO END THE
STATES ARE SUING THE FEDERAL GOVERNMENT TO END THE MASS REQUIREMENT.
GOVERNMENT TO END THE MASS REQUIREMENT. ON PUBLIC TRANSPORTATION
MASS REQUIREMENT. ON PUBLIC TRANSPORTATION CONGRESS
ON PUBLIC TRANSPORTATION CONGRESS HAVE MEET CONGRESS
CONGRESS HAVE MEET CONGRESS THE REPUBLICANS IN CONGRESS.
HAVE MEET CONGRESS THE REPUBLICANS IN CONGRESS. EXCUSE ME. MEANWHILE, HAD
THE REPUBLICANS IN CONGRESS. EXCUSE ME. MEANWHILE, HAD BALKED AT APPROVING NEW COVID
EXCUSE ME. MEANWHILE, HAD BALKED AT APPROVING NEW COVID FUNDING EVEN THOUGH WE ARE
BALKED AT APPROVING NEW COVID FUNDING EVEN THOUGH WE ARE A VERY MUCH AS I SAID,
FUNDING EVEN THOUGH WE ARE A VERY MUCH AS I SAID, STILL IN THIS PANDEMIC AND
A VERY MUCH AS I SAID, STILL IN THIS PANDEMIC AND PRESIDENT BIDEN
STILL IN THIS PANDEMIC AND PRESIDENT BIDEN WORN TODAY,
PRESIDENT BIDEN WORN TODAY, BUT WHAT WILL HAPPEN
WORN TODAY, BUT WHAT WILL HAPPEN IF CONGRESS FAILS TO ACT?
BUT WHAT WILL HAPPEN IF CONGRESS FAILS TO ACT? ACT IF CONGRESS FAILS
IF CONGRESS FAILS TO ACT? ACT IF CONGRESS FAILS TO ACT? WE WON‘T HAVE
ACT IF CONGRESS FAILS TO ACT? WE WON‘T HAVE THE SUPPLY. WE NEED THIS FALL
TO ACT? WE WON‘T HAVE THE SUPPLY. WE NEED THIS FALL TO ENSURE THE SHOTS ARE
THE SUPPLY. WE NEED THIS FALL TO ENSURE THE SHOTS ARE AVAILABLE FREE
TO ENSURE THE SHOTS ARE AVAILABLE FREE EASILY ACCESSIBLE FOR ALL
AVAILABLE FREE EASILY ACCESSIBLE FOR ALL AMERICANS,
EASILY ACCESSIBLE FOR ALL AMERICANS, EVEN WORSE.
AMERICANS, EVEN WORSE. IF WE NEED A DIFFERENT VACCINE
EVEN WORSE. IF WE NEED A DIFFERENT VACCINE FOR THE FUTURE TO COMBAT,
IF WE NEED A DIFFERENT VACCINE FOR THE FUTURE TO COMBAT, A NEW VARIANT. WE‘RE NOT GOING
FOR THE FUTURE TO COMBAT, A NEW VARIANT. WE‘RE NOT GOING PURCHASE IT.
A NEW VARIANT. WE‘RE NOT GOING PURCHASE IT. WE
PURCHASE IT. WE CANNOT ALLOW THAT.
WE NEED TO SECURE ADDITIONAL
WE NEED TO SECURE ADDITIONAL SUPPLY NOW.
WE NEED TO SECURE ADDITIONAL SUPPLY NOW. NOW
SUPPLY NOW. NOW WE CAN‘T WAIT, AS WE FIND
NOW WE CAN‘T WAIT, AS WE FIND ANOTHER SURGE TO ACT.
WE CAN‘T WAIT, AS WE FIND ANOTHER SURGE TO ACT. IT‘LL BE TOO LATE.
ANOTHER SURGE TO ACT. IT‘LL BE TOO LATE. STARTING US OFF TONIGHT. IS
IT‘LL BE TOO LATE. STARTING US OFF TONIGHT. IS DR. ANTHONY FAUCI.
STARTING US OFF TONIGHT. IS DR. ANTHONY FAUCI. CHIEF MEDICAL
DR. ANTHONY FAUCI. CHIEF MEDICAL ADVISER TO PRESIDENT BIDEN.
CHIEF MEDICAL ADVISER TO PRESIDENT BIDEN. THANK YOU SO MUCH FOR JOINING
ADVISER TO PRESIDENT BIDEN. THANK YOU SO MUCH FOR JOINING US TODAY.
THANK YOU SO MUCH FOR JOINING US TODAY. THANK YOU FOR HAVING ME
US TODAY. THANK YOU FOR HAVING ME PLEASURE TO BE WITH YOU.
THANK YOU FOR HAVING ME PLEASURE TO BE WITH YOU. SO
PLEASURE TO BE WITH YOU. SO CONGRESS TO PASS THE
SO CONGRESS TO PASS THE NEW COVID RELIEF AID.
CONGRESS TO PASS THE NEW COVID RELIEF AID. TELL US IN YOUR WORDS,
NEW COVID RELIEF AID. TELL US IN YOUR WORDS, OUR COUNTRY? IF
TELL US IN YOUR WORDS, OUR COUNTRY? IF THAT FUNDING IS NOT APPROVED
OUR COUNTRY? IF THAT FUNDING IS NOT APPROVED BY
THAT FUNDING IS NOT APPROVED BY CONGRESS.
BY CONGRESS. YES, THAT‘S REALLY A VERY,
CONGRESS. YES, THAT‘S REALLY A VERY, VERY IMPORTANT ISSUE.
YES, THAT‘S REALLY A VERY, VERY IMPORTANT ISSUE. WE‘VE.
VERY IMPORTANT ISSUE. WE‘VE. WE‘VE DONE VERY WELL. WE‘VE
WE‘VE. WE‘VE DONE VERY WELL. WE‘VE BEEN,
WE‘VE DONE VERY WELL. WE‘VE BEEN, WE‘VE HAD A LOT OF THE
BEEN, WE‘VE HAD A LOT OF THE GENEROSITY ON THE PART OF THE
WE‘VE HAD A LOT OF THE GENEROSITY ON THE PART OF THE ADMINISTRATION
GENEROSITY ON THE PART OF THE ADMINISTRATION AND THE CONGRESS
ADMINISTRATION AND THE CONGRESS CRITICAL POINT RIGHT NOW.
AND THE CONGRESS CRITICAL POINT RIGHT NOW. THAT THE PRESIDENT IS ASKING
CRITICAL POINT RIGHT NOW. THAT THE PRESIDENT IS ASKING FOR, THERE ARE TWO THINGS
THAT THE PRESIDENT IS ASKING FOR, THERE ARE TWO THINGS THAT WILL HAPPEN. THAT WOULD
FOR, THERE ARE TWO THINGS THAT WILL HAPPEN. THAT WOULD BE VERY UNFORTUNATE.
THAT WILL HAPPEN. THAT WOULD BE VERY UNFORTUNATE. WE WOULD HAVE TO STOP THE
BE VERY UNFORTUNATE. WE WOULD HAVE TO STOP THE PURCHASES OF THINGS LIKE,
WE WOULD HAVE TO STOP THE PURCHASES OF THINGS LIKE, MONOCLONAL.
PURCHASES OF THINGS LIKE, MONOCLONAL. ANYBODY‘S AND ANTIVIRALS, AS
MONOCLONAL. ANYBODY‘S AND ANTIVIRALS, AS WELL AS
ANYBODY‘S AND ANTIVIRALS, AS WELL AS VACCINES ACTUALLY THAT WE
WELL AS VACCINES ACTUALLY THAT WE IN A BOOSTER BOTH
VACCINES ACTUALLY THAT WE IN A BOOSTER BOTH IMMEDIATELY, AS WELL AS
IN A BOOSTER BOTH IMMEDIATELY, AS WELL AS BOOSTERS LATER ON AS WE GET
IMMEDIATELY, AS WELL AS BOOSTERS LATER ON AS WE GET INTO THE YEAR.
BOOSTERS LATER ON AS WE GET INTO THE YEAR. IN ADDITION, SOME OF THE
INTO THE YEAR. IN ADDITION, SOME OF THE PREPAREDNESS TO DO BETTER
IN ADDITION, SOME OF THE PREPAREDNESS TO DO BETTER WITH MORE ADVANCED.
PREPAREDNESS TO DO BETTER WITH MORE ADVANCED. PLATFORMS WITH MORE ADVANCED
WITH MORE ADVANCED. PLATFORMS WITH MORE ADVANCED VACCINE
PLATFORMS WITH MORE ADVANCED VACCINE CAPABILITIES, THAT WE HAVE.
VACCINE CAPABILITIES, THAT WE HAVE. THAT WOULD ALL COME TO EITHER.
VERY, VERY MUCH OF A
VERY, VERY MUCH OF A SLOW DOWN OR EVEN A STOP.
VERY, VERY MUCH OF A SLOW DOWN OR EVEN A STOP. SO,
SLOW DOWN OR EVEN A STOP. SO, THIS IS REALLY WEIRD.
SO, THIS IS REALLY WEIRD. AT THAT CRITICAL JUNCTURE
THIS IS REALLY WEIRD. AT THAT CRITICAL JUNCTURE RIGHT NOW. IF WE WANT TO KEEP
AT THAT CRITICAL JUNCTURE RIGHT NOW. IF WE WANT TO KEEP GOING
RIGHT NOW. IF WE WANT TO KEEP GOING VERY MUCH IN THE RIGHT
GOING VERY MUCH IN THE RIGHT DIRECTION TO WHERE WE‘RE DOING
VERY MUCH IN THE RIGHT DIRECTION TO WHERE WE‘RE DOING RIGHT NOW,
DIRECTION TO WHERE WE‘RE DOING RIGHT NOW, THEN WE REALLY DO NEED THAT
RIGHT NOW, THEN WE REALLY DO NEED THAT MONEY. SO THE PRESIDENT, WHEN
THEN WE REALLY DO NEED THAT MONEY. SO THE PRESIDENT, WHEN HE MADE THOSE
MONEY. SO THE PRESIDENT, WHEN HE MADE THOSE COMMENTS ABOUT NEEDING
HE MADE THOSE COMMENTS ABOUT NEEDING THE MONEY AND ALL OF US FEEL
COMMENTS ABOUT NEEDING THE MONEY AND ALL OF US FEEL THE SAME WAY THAT WE REALLY
THE MONEY AND ALL OF US FEEL THE SAME WAY THAT WE REALLY DO NEED IT. I MEAN, THIS IS
THE SAME WAY THAT WE REALLY DO NEED IT. I MEAN, THIS IS NOT SOMETHING THAT IS JUST
DO NEED IT. I MEAN, THIS IS NOT SOMETHING THAT IS JUST SAYING IT FOR THE SAKE OF
NOT SOMETHING THAT IS JUST SAYING IT FOR THE SAKE OF SAYING IT. IT‘S IMPORTANT.
SAYING IT FOR THE SAKE OF SAYING IT. IT‘S IMPORTANT. I MEAN, I KNOW SEVERAL OF THE
SAYING IT. IT‘S IMPORTANT. I MEAN, I KNOW SEVERAL OF THE THINGS
I MEAN, I KNOW SEVERAL OF THE THINGS THAT WE‘RE DOING AND THEY WERE
THINGS THAT WE‘RE DOING AND THEY WERE MANY AGENCIES THAT ARE
THAT WE‘RE DOING AND THEY WERE MANY AGENCIES THAT ARE INVOLVED. HERE. IT ISN‘T JUST
MANY AGENCIES THAT ARE INVOLVED. HERE. IT ISN‘T JUST THE NIH THAT I‘M
TRIALS,
TRIALS, THE FOLLOW-UPS ON THE CLINICAL
TRIALS, THE FOLLOW-UPS ON THE CLINICAL TRIALS THAT WE‘VE DONE.
THE FOLLOW-UPS ON THE CLINICAL TRIALS THAT WE‘VE DONE. WE, IF WE DON‘T HAVE MONEY, WE
TRIALS THAT WE‘VE DONE. WE, IF WE DON‘T HAVE MONEY, WE CAN‘T CONTINUE THEM. AND THESE
WE, IF WE DON‘T HAVE MONEY, WE CAN‘T CONTINUE THEM. AND THESE ARE IMPORTANT INFORMATION
CAN‘T CONTINUE THEM. AND THESE ARE IMPORTANT INFORMATION THAT WILL NEED FOR THE SAFETY,
ARE IMPORTANT INFORMATION THAT WILL NEED FOR THE SAFETY, UNDERSTANDING THESE VACCINES.
THAT WILL NEED FOR THE SAFETY, UNDERSTANDING THESE VACCINES. IS THE DELAY.
UNDERSTANDING THESE VACCINES. IS THE DELAY. THE FACT THAT THE FUNDING
IS THE DELAY. THE FACT THAT THE FUNDING HASN‘T BEEN APPROVED YET.
THE FACT THAT THE FUNDING HASN‘T BEEN APPROVED YET. ARE WE ALREADY BEHIND THE
HASN‘T BEEN APPROVED YET. ARE WE ALREADY BEHIND THE EIGHT BALL IN TERMS OF
ARE WE ALREADY BEHIND THE EIGHT BALL IN TERMS OF PREPARING FOR THE REST OF THE
EIGHT BALL IN TERMS OF PREPARING FOR THE REST OF THE YEAR AS YOU SAID? BECAUSE
PREPARING FOR THE REST OF THE YEAR AS YOU SAID? BECAUSE THE LAST TWO YEARS WE HAD A
YEAR AS YOU SAID? BECAUSE THE LAST TWO YEARS WE HAD A VARIANT TOWARDS THAT
THE LAST TWO YEARS WE HAD A VARIANT TOWARDS THAT THE END OF THAT YEAR, LATE
VARIANT TOWARDS THAT THE END OF THAT YEAR, LATE SUMMER, EARLY FALL
THE END OF THAT YEAR, LATE SUMMER, EARLY FALL BASICALLY FLU SEASON.
SUMMER, EARLY FALL BASICALLY FLU SEASON. KNOW. IT WOULD BE YOU KNOW, I
BASICALLY FLU SEASON. KNOW. IT WOULD BE YOU KNOW, I TO BE PERFECTLY HONEST AND
KNOW. IT WOULD BE YOU KNOW, I TO BE PERFECTLY HONEST AND FRANK
TO BE PERFECTLY HONEST AND FRANK RIGHT NOW.
FRANK RIGHT NOW. NOTHING HAS BEEN DELAYED.
RIGHT NOW. NOTHING HAS BEEN DELAYED. BUT IF WE DO,
NOTHING HAS BEEN DELAYED. BUT IF WE DO, NOT GET THE MONEY VERY
BUT IF WE DO, NOT GET THE MONEY VERY SOON.
NOT GET THE MONEY VERY SOON. THEN THINGS ARE GOING TO START
SOON. THEN THINGS ARE GOING TO START GETTING INTO TROUBLE. SO I
THEN THINGS ARE GOING TO START GETTING INTO TROUBLE. SO I WOULD NOT BE APPROPRIATE OR
GETTING INTO TROUBLE. SO I WOULD NOT BE APPROPRIATE OR ALREADY FALLEN BEHIND. WE‘VE
WOULD NOT BE APPROPRIATE OR ALREADY FALLEN BEHIND. WE‘VE NOT, BUT IF WE DON‘T GET THE
ALREADY FALLEN BEHIND. WE‘VE NOT, BUT IF WE DON‘T GET THE MONEY REALLY SOON, WE WILL
NOT, BUT IF WE DON‘T GET THE MONEY REALLY SOON, WE WILL START TO FALL BEHIND.
MONEY REALLY SOON, WE WILL START TO FALL BEHIND. IT‘S
START TO FALL BEHIND. IT‘S AN IMPORTANT POINT, THE BE A 2
IT‘S AN IMPORTANT POINT, THE BE A 2 SUB THERE. AND SPEAKING OF
AN IMPORTANT POINT, THE BE A 2 SUB THERE. AND SPEAKING OF VARIANTS DOESN‘T APPEAR TO
SUB THERE. AND SPEAKING OF VARIANTS DOESN‘T APPEAR TO CAUSE
VARIANTS DOESN‘T APPEAR TO CAUSE SEVERE ILLNESS IN MOST
CAUSE SEVERE ILLNESS IN MOST BUT ARE YOU CONCERNED THAT
SEVERE ILLNESS IN MOST BUT ARE YOU CONCERNED THAT PEOPLE WHO COULD
BUT ARE YOU CONCERNED THAT PEOPLE WHO COULD GET THE BE A
PEOPLE WHO COULD GET THE BE A TO VARIANT OR EVEN OMICRON?
GET THE BE A TO VARIANT OR EVEN OMICRON? OMICRON AND HAVE MILD
TO VARIANT OR EVEN OMICRON? OMICRON AND HAVE MILD SYMPTOMS?
OMICRON AND HAVE MILD SYMPTOMS? GETTING THE LONG HAUL
SYMPTOMS? GETTING THE LONG HAUL COVID AND
GETTING THE LONG HAUL COVID AND LAY OUT FOR US. YOU KNOW HOW
COVID AND LAY OUT FOR US. YOU KNOW HOW YOU SEE THE RISK
LAY OUT FOR US. YOU KNOW HOW YOU SEE THE RISK ASSESSMENTS?
YOU SEE THE RISK ASSESSMENTS? FACT THAT LONG
ASSESSMENTS? FACT THAT LONG COVID AND LAY OUT FOR US. YOU
FACT THAT LONG COVID AND LAY OUT FOR US. YOU KNOW HOW YOU SEE THE RISK
COVID AND LAY OUT FOR US. YOU KNOW HOW YOU SEE THE RISK ASSESSMENTS? PEOPLE ARE MAKING
KNOW HOW YOU SEE THE RISK ASSESSMENTS? PEOPLE ARE MAKING GIVEN THE FACT THAT LONG
ASSESSMENTS? PEOPLE ARE MAKING GIVEN THE FACT THAT LONG THE MORE WE LEARN ABOUT IT,
GIVEN THE FACT THAT LONG THE MORE WE LEARN ABOUT IT, THE MORE
THE MORE WE LEARN ABOUT IT, THE MORE WE‘RE FINDING THAT MORE PEOPLE
THE MORE WE‘RE FINDING THAT MORE PEOPLE ARE DEALING WITH THAT.
WE‘RE FINDING THAT MORE PEOPLE ARE DEALING WITH THAT. IT IS A SERIOUS ISSUE.
ARE DEALING WITH THAT. IT IS A SERIOUS ISSUE. OF PERCENTAGE ANYWHERE FROM
IT IS A SERIOUS ISSUE. OF PERCENTAGE ANYWHERE FROM OF PEOPLE
OF PERCENTAGE ANYWHERE FROM OF PEOPLE WHEN THEY RECOVER FROM
OF PEOPLE WHEN THEY RECOVER FROM SYNDROME OF COVID-19.
WHEN THEY RECOVER FROM SYNDROME OF COVID-19. EVEN IF YOU HAVE NOT HAD
SYNDROME OF COVID-19. EVEN IF YOU HAVE NOT HAD VERY, VERY
EVEN IF YOU HAVE NOT HAD VERY, VERY SEVERE DISEASE, EVEN PEOPLE
VERY, VERY SEVERE DISEASE, EVEN PEOPLE WITH MODERATE SYMPTOMS
SEVERE DISEASE, EVEN PEOPLE WITH MODERATE SYMPTOMS AND MILD SYMPTOMS
WITH MODERATE SYMPTOMS AND MILD SYMPTOMS CAN GO ON TO GET THE
AND MILD SYMPTOMS CAN GO ON TO GET THE PROLONGATION.
CAN GO ON TO GET THE PROLONGATION. AND THE PERSISTENCE OF
PROLONGATION. AND THE PERSISTENCE OF SIGNS AND SYMPTOMS
AND THE PERSISTENCE OF SIGNS AND SYMPTOMS THAT CAN BE ANYTHING FROM
SIGNS AND SYMPTOMS THAT CAN BE ANYTHING FROM INCAPACITATING. SO WE REALLY
THAT CAN BE ANYTHING FROM INCAPACITATING. SO WE REALLY DO NEED TO TAKE THAT VERY
INCAPACITATING. SO WE REALLY DO NEED TO TAKE THAT VERY SERIOUSLY, AS VERY INTERESTING
DO NEED TO TAKE THAT VERY SERIOUSLY, AS VERY INTERESTING TO KNOW
SERIOUSLY, AS VERY INTERESTING TO KNOW THAT PEOPLE WHO ARE
TO KNOW THAT PEOPLE WHO ARE VACCINATED
THAT PEOPLE WHO ARE VACCINATED WHO WIND UP GETTING
VACCINATED WHO WIND UP GETTING BREAKTHROUGH INFECTIONS HAVE
WHO WIND UP GETTING BREAKTHROUGH INFECTIONS HAVE LESS OF A CHANCE
BREAKTHROUGH INFECTIONS HAVE LESS OF A CHANCE OF GETTING
LESS OF A CHANCE OF GETTING COVID THAN PEOPLE WHO ARE
OF GETTING COVID THAN PEOPLE WHO ARE UNVACCINATED
COVID THAN PEOPLE WHO ARE UNVACCINATED AND GET INFECTED. AND THAT‘S
UNVACCINATED AND GET INFECTED. AND THAT‘S THE REASON WHY WE CONTINUE.
AND GET INFECTED. AND THAT‘S THE REASON WHY WE CONTINUE. TO IN MANY RESPECTS,
THE REASON WHY WE CONTINUE. TO IN MANY RESPECTS, REALLY PLEAD WITH THE
TO IN MANY RESPECTS, REALLY PLEAD WITH THE AMERICAN PUBLIC.
REALLY PLEAD WITH THE AMERICAN PUBLIC. IF YOU‘VE NOT BEEN VACCINATED
AMERICAN PUBLIC. IF YOU‘VE NOT BEEN VACCINATED TO GET VACCINATED,
IF YOU‘VE NOT BEEN VACCINATED TO GET VACCINATED, IF YOU HAVE BEEN VACCINATED
TO GET VACCINATED, IF YOU HAVE BEEN VACCINATED SHOTS
IF YOU HAVE BEEN VACCINATED SHOTS BECAUSE PARTICULARLY IN THE
SHOTS BECAUSE PARTICULARLY IN THE ARENA AND THE ERA OF
BECAUSE PARTICULARLY IN THE ARENA AND THE ERA OF COVID
ARENA AND THE ERA OF COVID BOOSTERS ARE PLAYING A MAJOR
COVID BOOSTERS ARE PLAYING A MAJOR ROLE IN GETTING
BOOSTERS ARE PLAYING A MAJOR ROLE IN GETTING THE LEVEL OF PROTECTION.
ROLE IN GETTING THE LEVEL OF PROTECTION. HIGH ENOUGH.
THE LEVEL OF PROTECTION. HIGH ENOUGH. PARTICULARLY TO PREVENT YOU
HIGH ENOUGH. PARTICULARLY TO PREVENT YOU FROM GETTING SEVERE DISEASE.
PARTICULARLY TO PREVENT YOU FROM GETTING SEVERE DISEASE. SO THERE‘S EVERY REASON IN THE
FROM GETTING SEVERE DISEASE. SO THERE‘S EVERY REASON IN THE WORLD NOW TO GET
SO THERE‘S EVERY REASON IN THE WORLD NOW TO GET VACCINATED
WORLD NOW TO GET VACCINATED AND TO GET
VACCINATED AND TO GET BOOSTED.
AND TO GET BOOSTED. SO, THAT WAS MY NEXT QUESTION
BOOSTED. SO, THAT WAS MY NEXT QUESTION BECAUSE
SO, THAT WAS MY NEXT QUESTION BECAUSE NOW THAT IT IS
BECAUSE NOW THAT IT IS APPROVED FOR ADULTS WHO ARE 50
NOW THAT IT IS APPROVED FOR ADULTS WHO ARE 50 AND UP OR IMMUNE
APPROVED FOR ADULTS WHO ARE 50 AND UP OR IMMUNE COMPROMISE TO GET THAT SECOND
AND UP OR IMMUNE COMPROMISE TO GET THAT SECOND BOOSTER, WHICH IS NOT THE
COMPROMISE TO GET THAT SECOND BOOSTER, WHICH IS NOT THE FIRST BOOSTER
BOOSTER, WHICH IS NOT THE FIRST BOOSTER OR THE EXTRA SHOT. IF YOU ONLY
FIRST BOOSTER OR THE EXTRA SHOT. IF YOU ONLY GOT THE J&J, THERE‘S
OR THE EXTRA SHOT. IF YOU ONLY GOT THE J&J, THERE‘S SOME CAVEATS HERE DEPENDING
GOT THE J&J, THERE‘S SOME CAVEATS HERE DEPENDING UPON
SOME CAVEATS HERE DEPENDING UPON HOW EVERYBODY STARTED WITH
UPON HOW EVERYBODY STARTED WITH THEIR VACCINATIONS PROCESS,
HOW EVERYBODY STARTED WITH THEIR VACCINATIONS PROCESS, BUT HOW
THEIR VACCINATIONS PROCESS, BUT HOW SHOULD PEOPLE THINK ABOUT THAT
BUT HOW SHOULD PEOPLE THINK ABOUT THAT SECOND BOOSTER SHOT WHEN YOU
SHOULD PEOPLE THINK ABOUT THAT SECOND BOOSTER SHOT WHEN YOU SAY THAT IT
SECOND BOOSTER SHOT WHEN YOU SAY THAT IT IMPROVES, YOU KNOW, THE
SAY THAT IT IMPROVES, YOU KNOW, THE EFFICACY
IMPROVES, YOU KNOW, THE EFFICACY OF THE
EFFICACY OF THE MAXINE
OF THE MAXINE WAYNE‘S, RIGHT? AND THIS IS
MAXINE WAYNE‘S, RIGHT? AND THIS IS THESE BOOSTERS
WAYNE‘S, RIGHT? AND THIS IS THESE BOOSTERS HELP. PEOPLE UNDERSTAND WHY
THESE BOOSTERS HELP. PEOPLE UNDERSTAND WHY THAT IS, I THINK PEOPLE ARE
HELP. PEOPLE UNDERSTAND WHY THAT IS, I THINK PEOPLE ARE LIKE, WHY DO THEY KEEP TELLING
THAT IS, I THINK PEOPLE ARE LIKE, WHY DO THEY KEEP TELLING ME? I NEED ANOTHER SHOT.
LIKE, WHY DO THEY KEEP TELLING ME? I NEED ANOTHER SHOT. AND, AND IT CAN SEEM A LITTLE
ME? I NEED ANOTHER SHOT. AND, AND IT CAN SEEM A LITTLE BIT FRUSTRATING. IF YOU DON‘T
AND, AND IT CAN SEEM A LITTLE BIT FRUSTRATING. IF YOU DON‘T UNDERSTAND THE SCIENCE.
BIT FRUSTRATING. IF YOU DON‘T UNDERSTAND THE SCIENCE. WELL, YEAH.
UNDERSTAND THE SCIENCE. WELL, YEAH. WELL TRY TO MAKE IT AS
WELL, YEAH. WELL TRY TO MAKE IT AS SIMPLE AS POSSIBLE
WELL TRY TO MAKE IT AS SIMPLE AS POSSIBLE WITH ALL OF THE
SIMPLE AS POSSIBLE WITH ALL OF THE VACCINES THAT YOU HAVE
WITH ALL OF THE VACCINES THAT YOU HAVE OVER A PERIOD OF TIME.
VACCINES THAT YOU HAVE OVER A PERIOD OF TIME. PARTICULARLY WHEN YOU‘RE
OVER A PERIOD OF TIME. PARTICULARLY WHEN YOU‘RE DEALING
PARTICULARLY WHEN YOU‘RE DEALING WITH A SAWS
DEALING WITH A SAWS CORONAVIRUS.
WITH A SAWS CORONAVIRUS. DIFFERENT VIRUSES AND
CORONAVIRUS. DIFFERENT VIRUSES AND DIFFERENT VACCINES
DIFFERENT VIRUSES AND DIFFERENT VACCINES HAVE
DIFFERENT VACCINES HAVE VARIABLE DEGREES OF
HAVE VARIABLE DEGREES OF DURABILITY OF
VARIABLE DEGREES OF DURABILITY OF PROTECTION. A GIVE YOU AN
DURABILITY OF PROTECTION. A GIVE YOU AN EXAMPLE,
PROTECTION. A GIVE YOU AN EXAMPLE, IF YOU GET A MEASLES
EXAMPLE, IF YOU GET A MEASLES VACCINE REGIMEN THAT
IF YOU GET A MEASLES VACCINE REGIMEN THAT WE GET AS A CHILD, THAT
VACCINE REGIMEN THAT WE GET AS A CHILD, THAT IS
WE GET AS A CHILD, THAT IS DURABLE,
IS DURABLE, ESSENTIALLY FOR THE REST OF
DURABLE, ESSENTIALLY FOR THE REST OF YOUR LIFE FOR MOST
ESSENTIALLY FOR THE REST OF YOUR LIFE FOR MOST PEOPLE. NOT EVERYONE
YOUR LIFE FOR MOST PEOPLE. NOT EVERYONE OBVIOUSLY, BUT
PEOPLE. NOT EVERYONE OBVIOUSLY, BUT FOR MOST PEOPLE
OBVIOUSLY, BUT FOR MOST PEOPLE THAT‘S NOT THE CASE WHEN
FOR MOST PEOPLE THAT‘S NOT THE CASE WHEN YOU‘RE DEALING
THAT‘S NOT THE CASE WHEN YOU‘RE DEALING WITH COVID AND SAWS
YOU‘RE DEALING WITH COVID AND SAWS COVEY TO, OR ANY CORONAVIRUS,
WITH COVID AND SAWS COVEY TO, OR ANY CORONAVIRUS, THE
COVEY TO, OR ANY CORONAVIRUS, THE OF THE VIRUS
THE OF THE VIRUS AND THE NATURE OF THE VACCINE
OF THE VIRUS AND THE NATURE OF THE VACCINE IN THE BODY‘S RESPONSE
AND THE NATURE OF THE VACCINE IN THE BODY‘S RESPONSE MEANS, YOU GET GOOD PROTECTION
IN THE BODY‘S RESPONSE MEANS, YOU GET GOOD PROTECTION FOLLOWING INFECTION
MEANS, YOU GET GOOD PROTECTION FOLLOWING INFECTION AND YOU GET GOOD PROTECTION
FOLLOWING INFECTION AND YOU GET GOOD PROTECTION FOLLOWING VACCINATION,
AND YOU GET GOOD PROTECTION FOLLOWING VACCINATION, BUT IT DOESN‘T LAST
FOLLOWING VACCINATION, BUT IT DOESN‘T LAST AN INDEFINITE PERIOD OF TIME
BUT IT DOESN‘T LAST AN INDEFINITE PERIOD OF TIME WHICH MEANS IF
AN INDEFINITE PERIOD OF TIME WHICH MEANS IF THIS HIGH AFTER CERTAIN PERIOD
WHICH MEANS IF THIS HIGH AFTER CERTAIN PERIOD OF TIME,
THIS HIGH AFTER CERTAIN PERIOD OF TIME, IT STARTS TO DIMINISH AND
OF TIME, IT STARTS TO DIMINISH AND DIMINISH
IT STARTS TO DIMINISH AND DIMINISH COMPLICATING ISSUE IS THAT WE
DIMINISH COMPLICATING ISSUE IS THAT WE HAVE
COMPLICATING ISSUE IS THAT WE HAVE VARIANTS. AND THAT‘S THE
HAVE VARIANTS. AND THAT‘S THE REASON WHY WHEN YOU HAVE BE A
VARIANTS. AND THAT‘S THE REASON WHY WHEN YOU HAVE BE A 1
REASON WHY WHEN YOU HAVE BE A 1 VERSUS DELTA
1 VERSUS DELTA VS. OUT THERE THAT THEY‘RE A
VERSUS DELTA VS. OUT THERE THAT THEY‘RE A BIT DIFFERENT FROM EACH OTHER.
VS. OUT THERE THAT THEY‘RE A BIT DIFFERENT FROM EACH OTHER. SO THE OPTIMAL PROTECTION
BIT DIFFERENT FROM EACH OTHER. SO THE OPTIMAL PROTECTION IF YOU WANT TO KEEP IT UP.
SO THE OPTIMAL PROTECTION IF YOU WANT TO KEEP IT UP. THAT‘S THE REASON FOR THE
IF YOU WANT TO KEEP IT UP. THAT‘S THE REASON FOR THE RECOMMENDATION OF THE BOOSTER.
THAT‘S THE REASON FOR THE RECOMMENDATION OF THE BOOSTER. THAT‘S POINT. NUMBER ONE,
RECOMMENDATION OF THE BOOSTER. THAT‘S POINT. NUMBER ONE, POINT. NUMBER TWO, WE KNOW,
THAT‘S POINT. NUMBER ONE, POINT. NUMBER TWO, WE KNOW, FROM EXPERIENCE
POINT. NUMBER TWO, WE KNOW, FROM EXPERIENCE WITH
FROM EXPERIENCE WITH IMMUNOLOGY IN GENERAL. IS THAT
WITH IMMUNOLOGY IN GENERAL. IS THAT AS YOU GET OLDER?
IMMUNOLOGY IN GENERAL. IS THAT AS YOU GET OLDER? OLDER, THE ROBUSTNESS
AS YOU GET OLDER? OLDER, THE ROBUSTNESS OF YOUR IMMUNE RESPONSE
OLDER, THE ROBUSTNESS OF YOUR IMMUNE RESPONSE DIMINISHES.
OF YOUR IMMUNE RESPONSE DIMINISHES. FACT OF LIFE,
DIMINISHES. FACT OF LIFE, MORE
FACT OF LIFE, MORE IN SOME
MORE IN SOME VERSUS OTHER. AND THAT‘S THE
IN SOME VERSUS OTHER. AND THAT‘S THE REASON WHY WHEN THE FDA
VERSUS OTHER. AND THAT‘S THE REASON WHY WHEN THE FDA LOOKED AT THE DATA
REASON WHY WHEN THE FDA LOOKED AT THE DATA BOTH
LOOKED AT THE DATA BOTH DATA THAT‘S BEING COLLECTED IN
BOTH DATA THAT‘S BEING COLLECTED IN THE UNITED STATES
DATA THAT‘S BEING COLLECTED IN THE UNITED STATES AS WELL AS DATA FROM A VERY
THE UNITED STATES AS WELL AS DATA FROM A VERY LARGE COHORT IN
AS WELL AS DATA FROM A VERY LARGE COHORT IN ISRAEL. THEY MADE THE
LARGE COHORT IN ISRAEL. THEY MADE THE DETERMINATION
ISRAEL. THEY MADE THE DETERMINATION THAT THEY WERE GOING TO
DETERMINATION THAT THEY WERE GOING TO AUTHORIZE
THAT THEY WERE GOING TO AUTHORIZE THE
AUTHORIZE THE ADDITIONAL SHOT. NAMELY, THE
THE ADDITIONAL SHOT. NAMELY, THE FOURTH SHOT OF AN
ADDITIONAL SHOT. NAMELY, THE FOURTH SHOT OF AN MRNA,
FOURTH SHOT OF AN MRNA, BUT PEOPLE WHO HAVE 50 YEARS
MRNA, BUT PEOPLE WHO HAVE 50 YEARS OF AGE ARE OLD AND
BUT PEOPLE WHO HAVE 50 YEARS OF AGE ARE OLD AND FOR PEOPLE WHO, IN FACT MIGHT
OF AGE ARE OLD AND FOR PEOPLE WHO, IN FACT MIGHT HAVE SOME UNDERLYING
FOR PEOPLE WHO, IN FACT MIGHT HAVE SOME UNDERLYING IMMUNE
HAVE SOME UNDERLYING IMMUNE DEFICIENCY.
IMMUNE DEFICIENCY. ONE, WE HAVE A VIRUS THAT‘S
DEFICIENCY. ONE, WE HAVE A VIRUS THAT‘S CHANGES IN THE OTHER. THE
ONE, WE HAVE A VIRUS THAT‘S CHANGES IN THE OTHER. THE DURABILITY DOESN‘T LAST AS
CHANGES IN THE OTHER. THE DURABILITY DOESN‘T LAST AS LONG.
DURABILITY DOESN‘T LAST AS LONG. THAT WAS HELPFUL. AND I THINK
LONG. THAT WAS HELPFUL. AND I THINK THAT FOLKS AT HOME WE ABLE
THAT WAS HELPFUL. AND I THINK THAT FOLKS AT HOME WE ABLE TO DIGEST THAT
THAT FOLKS AT HOME WE ABLE TO DIGEST THAT WE DIDN‘T ALL GO TO SCHOOL FOR
TO DIGEST THAT WE DIDN‘T ALL GO TO SCHOOL FOR IMMUNOLOGY, BUT WE CAN WE
WE DIDN‘T ALL GO TO SCHOOL FOR IMMUNOLOGY, BUT WE CAN WE CAN
IMMUNOLOGY, BUT WE CAN WE CAN SPEAK TO YOU AND YOU CAN
CAN SPEAK TO YOU AND YOU CAN HELP US WITH THIS ONE OF THE
SPEAK TO YOU AND YOU CAN HELP US WITH THIS ONE OF THE THINGS THAT I THINK A LOT OF
HELP US WITH THIS ONE OF THE THINGS THAT I THINK A LOT OF FOLKS
THINGS THAT I THINK A LOT OF FOLKS POST OMICRON
FOLKS POST OMICRON THEIR MINDSET SHIFTED A LITTLE
POST OMICRON THEIR MINDSET SHIFTED A LITTLE BIT,
THEIR MINDSET SHIFTED A LITTLE BIT, BECAUSE THEY CAUGHT OMICRON.
BIT, BECAUSE THEY CAUGHT OMICRON. RECOVERED FROM IT
BECAUSE THEY CAUGHT OMICRON. RECOVERED FROM IT AND
RECOVERED FROM IT AND THEY‘RE LIKE, ALL RIGHT, WE
AND THEY‘RE LIKE, ALL RIGHT, WE CAN GO OUT HERE. I DON‘T NEED
THEY‘RE LIKE, ALL RIGHT, WE CAN GO OUT HERE. I DON‘T NEED A MASK. I‘M FEELING GOOD. I
CAN GO OUT HERE. I DON‘T NEED A MASK. I‘M FEELING GOOD. I ALREADY HAD
A MASK. I‘M FEELING GOOD. I ALREADY HAD COVID. CAN YOU?
ALREADY HAD COVID. CAN YOU? IN WHY THEY
COVID. CAN YOU? IN WHY THEY EVEN
IN WHY THEY EVEN MIGHT WANT TO CONSIDER OR
EVEN MIGHT WANT TO CONSIDER OR SHOULD CONSIDER IN YOUR VIEW.
MIGHT WANT TO CONSIDER OR SHOULD CONSIDER IN YOUR VIEW. A BOOSTER SHOT
SHOULD CONSIDER IN YOUR VIEW. A BOOSTER SHOT THAT SECOND BOOSTER SHOT AND
A BOOSTER SHOT THAT SECOND BOOSTER SHOT AND WHY THAT
THAT SECOND BOOSTER SHOT AND WHY THAT IMMUNITY FROM
WHY THAT IMMUNITY FROM OR IF IT IS
IMMUNITY FROM OR IF IT IS FROM IMMUNITY FROM THAT
OR IF IT IS FROM IMMUNITY FROM THAT BOOSTER
FROM IMMUNITY FROM THAT BOOSTER IN TERMS.
BOOSTER IN TERMS. OF RISK FOR
IN TERMS. OF RISK FOR RE INFECTION, WHICH IS ANOTHER
OF RISK FOR RE INFECTION, WHICH IS ANOTHER PIECE OF
RE INFECTION, WHICH IS ANOTHER PIECE OF ON. AND I WANTED TO ASK YOU
PIECE OF ON. AND I WANTED TO ASK YOU ABOUT,
ON. AND I WANTED TO ASK YOU ABOUT, EXACTLY WHAT YOU AND I WERE
ABOUT, EXACTLY WHAT YOU AND I WERE JUST DISCUSSING
EXACTLY WHAT YOU AND I WERE JUST DISCUSSING A MOMENT AGO
JUST DISCUSSING A MOMENT AGO THAT THE DURABILITY OF
A MOMENT AGO THAT THE DURABILITY OF PROTECTION
THAT THE DURABILITY OF PROTECTION IS NOT
PROTECTION IS NOT INDEFINITE. IT TENDS TO
IS NOT INDEFINITE. IT TENDS TO WANE.
INDEFINITE. IT TENDS TO WANE. THAT‘S EXACTLY THE SAME.
WANE. THAT‘S EXACTLY THE SAME. FOR THE
THAT‘S EXACTLY THE SAME. FOR THE DURABILITY
FOR THE DURABILITY OF PROTECTION,
DURABILITY OF PROTECTION, FOLLOWING NATURAL INFECTION.
OF PROTECTION, FOLLOWING NATURAL INFECTION. SO,
FOLLOWING NATURAL INFECTION. SO, IF YOU GET INFECTED
SO, IF YOU GET INFECTED AND YOU RECOVER AND YOU
IF YOU GET INFECTED AND YOU RECOVER AND YOU DO, WELL, YOU HAVE A
AND YOU RECOVER AND YOU DO, WELL, YOU HAVE A DEGREE OF PROTECTION,
DO, WELL, YOU HAVE A DEGREE OF PROTECTION, THAT‘S REAL AND IT‘S GOOD,
DEGREE OF PROTECTION, THAT‘S REAL AND IT‘S GOOD, BUT
THAT‘S REAL AND IT‘S GOOD, BUT SIMILAR TO
BUT SIMILAR TO VACCINATION, IT DOESN‘T LAST
SIMILAR TO VACCINATION, IT DOESN‘T LAST FOR A VERY LONG
VACCINATION, IT DOESN‘T LAST FOR A VERY LONG PERIOD OF TIME IN
FOR A VERY LONG PERIOD OF TIME IN MOST PEOPLE. REMEMBER THERE‘S
PERIOD OF TIME IN MOST PEOPLE. REMEMBER THERE‘S A LOT OF VARIABILITY
MOST PEOPLE. REMEMBER THERE‘S A LOT OF VARIABILITY AMONG PEOPLE THAT IS JUST IN
A LOT OF VARIABILITY AMONG PEOPLE THAT IS JUST IN EVERY SINGLE ISSUE OF LIFE,
AMONG PEOPLE THAT IS JUST IN EVERY SINGLE ISSUE OF LIFE, WHEN YOU TALK ABOUT DISEASES
EVERY SINGLE ISSUE OF LIFE, WHEN YOU TALK ABOUT DISEASES AND RESPONSES TO DISEASES.
WHEN YOU TALK ABOUT DISEASES AND RESPONSES TO DISEASES. THE ONE THING THAT IS
AND RESPONSES TO DISEASES. THE ONE THING THAT IS INTERESTING AND IMPORTANT
THE ONE THING THAT IS INTERESTING AND IMPORTANT IS THAT
INTERESTING AND IMPORTANT IS THAT THE
IS THAT THE ABSOLUTE BEST
THE ABSOLUTE BEST PROTECTION
ABSOLUTE BEST PROTECTION WAS IF YOU DO, GET INFECTED,
PROTECTION WAS IF YOU DO, GET INFECTED, AND THEN YOU GET
WAS IF YOU DO, GET INFECTED, AND THEN YOU GET VACCINATED, YOU BRING UP YOUR
AND THEN YOU GET VACCINATED, YOU BRING UP YOUR RESPONSE TO THE
VACCINATED, YOU BRING UP YOUR RESPONSE TO THE HIGHEST POSSIBLE LEVEL.
RESPONSE TO THE HIGHEST POSSIBLE LEVEL. SO IF PEOPLE
HIGHEST POSSIBLE LEVEL. SO IF PEOPLE WHO‘VE BEEN INFECTED
SO IF PEOPLE WHO‘VE BEEN INFECTED WANT TO PROTECT THEMSELVES
WHO‘VE BEEN INFECTED WANT TO PROTECT THEMSELVES FROM
WANT TO PROTECT THEMSELVES FROM REINFECTION,
FROM REINFECTION, THE EASIEST THING TO DO IS TO
REINFECTION, THE EASIEST THING TO DO IS TO GET VACCINATED BECAUSE THEN
THE EASIEST THING TO DO IS TO GET VACCINATED BECAUSE THEN YOUR RESPONSE WILL BE VERY
GET VACCINATED BECAUSE THEN YOUR RESPONSE WILL BE VERY HIGH. THAT DOESN‘T MEAN THAT
YOUR RESPONSE WILL BE VERY HIGH. THAT DOESN‘T MEAN THAT YOU DON‘T HAVE SOME PROTECTION
HIGH. THAT DOESN‘T MEAN THAT YOU DON‘T HAVE SOME PROTECTION YOU REALLY WANT TO
YOU DON‘T HAVE SOME PROTECTION YOU REALLY WANT TO GET IT UP,
YOU REALLY WANT TO GET IT UP, UP TO THE OPTIMAL LEVEL.
GET IT UP, UP TO THE OPTIMAL LEVEL. THAT‘S THE REASON WHY THE
UP TO THE OPTIMAL LEVEL. THAT‘S THE REASON WHY THE FDA AND THE CDC.
THAT‘S THE REASON WHY THE FDA AND THE CDC. RECOMMEND THAT YOU DO GET
FDA AND THE CDC. RECOMMEND THAT YOU DO GET VACCINATED EVEN IF YOU‘VE BEEN
RECOMMEND THAT YOU DO GET VACCINATED EVEN IF YOU‘VE BEEN INFECTED.
VACCINATED EVEN IF YOU‘VE BEEN INFECTED. I‘LL IT‘S REALLY HELPFUL FOR
INFECTED. I‘LL IT‘S REALLY HELPFUL FOR PEOPLE TO UNDERSTAND BECAUSE I
I‘LL IT‘S REALLY HELPFUL FOR PEOPLE TO UNDERSTAND BECAUSE I KNOW THERE‘S A MINDSET
PEOPLE TO UNDERSTAND BECAUSE I KNOW THERE‘S A MINDSET BETWEEN PEOPLE WHO HAVE HAD
KNOW THERE‘S A MINDSET BETWEEN PEOPLE WHO HAVE HAD COVID AND WHO HAVEN‘T HAD
BETWEEN PEOPLE WHO HAVE HAD COVID AND WHO HAVEN‘T HAD COVID. IT‘S VERY DIFFERENT IN
COVID AND WHO HAVEN‘T HAD COVID. IT‘S VERY DIFFERENT IN THIS PARTICULAR MOMENT, WHICH
COVID. IT‘S VERY DIFFERENT IN THIS PARTICULAR MOMENT, WHICH IS WHY I THINK
THIS PARTICULAR MOMENT, WHICH IS WHY I THINK THERE‘S SO MUCH
IS WHY I THINK THERE‘S SO MUCH TENSION OVER MASKING AND
THERE‘S SO MUCH TENSION OVER MASKING AND MITIGATION MEASURES
TENSION OVER MASKING AND MITIGATION MEASURES RIGHT NOW BECAUSE A LOT OF
MITIGATION MEASURES RIGHT NOW BECAUSE A LOT OF PEOPLE HAVE HAD COVID AND
RIGHT NOW BECAUSE A LOT OF PEOPLE HAVE HAD COVID AND I‘VE ALREADY HAD IT. WHAT‘S
PEOPLE HAVE HAD COVID AND I‘VE ALREADY HAD IT. WHAT‘S THE BIG DEAL?
I‘VE ALREADY HAD IT. WHAT‘S THE BIG DEAL? IT‘S STILL A BIG DEAL.
THE BIG DEAL? IT‘S STILL A BIG DEAL. DR. ANTHONY. FAUCI. I REALLY
IT‘S STILL A BIG DEAL. DR. ANTHONY. FAUCI. I REALLY APPRECIATE YOU TAKING THE TIME
DR. ANTHONY. FAUCI. I REALLY APPRECIATE YOU TAKING THE TIME TO ANSWER OUR QUESTIONS AND
APPRECIATE YOU TAKING THE TIME TO ANSWER OUR QUESTIONS AND HELP US
TO ANSWER OUR QUESTIONS AND HELP US UNDERSTAND THAT ALL
HELP US UNDERSTAND THAT ALL THIS STUFF IS
UNDERSTAND THAT ALL THIS STUFF IS IT‘S DIFFICULT, BUT WE‘RE
THIS STUFF IS IT‘S DIFFICULT, BUT WE‘RE GRATEFUL TO YOU FOR HELPING
IT‘S DIFFICULT, BUT WE‘RE GRATEFUL TO YOU FOR HELPING PLEASE STAY.
GRATEFUL TO YOU FOR HELPING PLEASE STAY. THANK YOU. THANK YOU. THANK